Literature DB >> 9050982

Epidemiology of hypertension and insulin resistance syndrome.

S M Haffner1.   

Abstract

UNLABELLED: INSULIN RESISTANCE SYNDROME: Insulin resistance syndrome (syndrome X) indicates that insulin resistance is associated with and may be the cause of several metabolic conditions including hypertension, dyslipidemia, non-insulin dependent diabetes mellitus (NIDDM). HYPERTENSION: Although the association between insulin resistance and hypertension remains somewhat controversial, hypertensive subjects are clearly at increased risk of developing NIDDM. Insulin concentrations are a relatively weak predictor of the development of hypertension. It is possible that the relation between insulin, blood pressure and atherosclerosis may be weaker in blacks. However, antihypertensive agents that worsen insulin resistance may further increase the risk of NIDDM already present in subjects with hypertension.

Entities:  

Mesh:

Year:  1997        PMID: 9050982     DOI: 10.1097/00004872-199715011-00003

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  6 in total

Review 1.  Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems.

Authors:  Paul Ernsberger; Richard J Koletsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-17       Impact factor: 3.000

2.  The effects of the renin-angiotensin-aldosterone system gene polymorphisms on insulin resistance in hypertensive families.

Authors:  Chin-Fu Hsiao; Wayne W H Sheu; Yi-Jen Hung; Ming-Wei Lin; David Curb; Koustubh Ranadex; Thomas Quertermous; Yue-Ming Chen; Ida Yi-Der Chen; Kwan-Dun Wu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-03-14       Impact factor: 1.636

Review 3.  Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus.

Authors:  Samar Singh; Jyoti Bhat; Ping H Wang
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

Review 4.  Effects of thiazolidinediones on blood pressure.

Authors:  Thomas D Giles; Gary E Sander
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

5.  The Interaction of a Diabetes Gene Risk Score With 3 Different Antihypertensive Medications for Incident Glucose-level Elevation.

Authors:  Joshua I Barzilay; Dejian Lai; Barry R Davis; Sara Pressel; Hannah E Previn; Donna K Arnett
Journal:  Am J Hypertens       Date:  2019-03-16       Impact factor: 2.689

6.  A meta-analysis of the effect of thiazolidinediones on blood pressure.

Authors:  Rehan Qayyum; Jurga Adomaityte
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-01       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.